Company Monitoring Page for Orexigen

latest headlines for company on cafepharma

Analyst: FDA Won't Pull Permit On Orexigen Therapeutics
Yahoo/Benzinga
Sat, 03/7/15 - 11:09 am
Tags:
FDA, Orexigen, Contrave
Top FDA Official Says Orexigen Study Result 'Unreliable,' 'Misleading'
Forbes
Fri, 03/6/15 - 07:43 am
Tags:
FDA, Orexigen, Contrave
Takeda Disagrees With Orexigen Over Data Disclosure
Forbes
Thu, 03/5/15 - 05:37 pm
Tags:
Takeda, Orexigen, Contrave
The FDA Is Forcing Orexigen To Do A Second Safety Study Because Of Contrave Disclosures
Forbes
Wed, 03/4/15 - 08:26 am
Tags:
FDA, Orexigen, Contrave
Orexigen Soars On Obesity Drug's Surprise Health Boon
Investors.com
Wed, 03/4/15 - 08:14 am
Tags:
Orexigen, Contrave
Orexigen misses 4Q profit forecasts
Yahoo/AP
Wed, 02/25/15 - 04:52 pm
Tags:
Orexigen, earnings
Obesity Drugs: Orexigen Gains Market Share at Expense of Arena, Vivus
TheStreet.com
Sat, 02/21/15 - 09:44 am
Tags:
obesity, Orexigen, Arena, Vivus, Belviq, Contrave, Qsymia
Vivus' Qsymia Experiencing Both Prescription Growth And Market Share Erosion
Seeking Alpha
Wed, 02/18/15 - 10:52 am
Tags:
Vivus, Qsymia, obesity, Orexigen, Arena Pharmaceuticals, Contrave, Belviq
Orexigen Provides Progress Update on Mysimba European Marketing Authorization
Yahoo
Mon, 02/9/15 - 06:16 pm
Tags:
Orexigen, Europe, Mysimba, Contrave
Orexigen: Contrave Scripts Slow Down - Competition Lowers Price
Seeking Alpha
Tue, 02/3/15 - 09:01 am
Tags:
Orexigen, Contrave, obesity
Arena - Flat Scripts Is Not A Good Start To 2015
Seeking Alpha
Wed, 01/28/15 - 08:06 am
Tags:
Arena Pharmaceuticals, Eisai, Belviq, obesity, Contrave, Orexigen
Orexigen Scripts Continue Impressive Track
Seeking Alpha
Wed, 01/21/15 - 06:02 pm
Tags:
Orexigen, obesity, Contrave
5 Obesity Stocks Investors Are Watching
Yahoo/Benzinga
Thu, 01/15/15 - 08:53 am
Tags:
obesity, Orexigen, Contrave, Arena Pharmaceuticals, Belviq, APD334, Vivus, Qsymia, EnteroMedics, devices, Maestro System, Novo Nordisk, Saxenda
Orexigen's Contrave May Have Pricing Competition
Seeking Alpha
Mon, 01/12/15 - 09:47 am
Tags:
Orexigen, Contrave, drug pricing, Belviq, Arena Pharmaceuticals
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1
TheStreet.com
Fri, 01/9/15 - 09:17 am
Tags:
Celgene, Gilead Sciences, Express Scripts, Biogen Idec, Amicus Therapeutics, NPS Pharmaceuticals, Sanofi, Acadia, Orexigen, Pharmacyclics, Vertex Pharmaceuticals
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Yahoo/Benzinga
Wed, 12/31/14 - 10:37 am
Tags:
biotech, Threshold Pharmaceuticals, Acceleron, Spectrum Pharmaceuticals, Ultragenyx, Argos Therapeutics, OncoMed, Peregrine Pharmaceuticals, Incyte, Calithera, Array Biopharma, Theravance, Puma Biotechnology, CTI BioPharma, Orexigen, Enanta Pharmaceuticals, Sucampo, Exelixis, Cubist Pharmaceuticals, United Therapeutics
Orexigen - Contrave Script Numbers Remain Impressive
Seeking Alpha
Mon, 12/22/14 - 04:52 pm
Tags:
Orexigen, Contrave, obesity
Orexigen diet pill recommended for approval in Europe
Yahoo/Reuters
Fri, 12/19/14 - 09:46 am
Tags:
Orexigen, obesity, Contrave, Europe, Mysimba
Obesity Pill Upstart Orexigen Therapeutics Gaining on Rivals
Adam on Biotech Stocks
Fri, 12/12/14 - 12:33 pm
Tags:
obesity, Orexigen, Contrave, Arena Pharmaceuticals, Belviq, Vivus, Qsymia
Assessing The Beginnings Of The Orexigen Launch Of Contrave
Seeking Alpha
Wed, 12/10/14 - 05:46 pm
Tags:
Contrave, obesity, Orexigen, drug launches, Takeda

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.